Home Applications 761262 Application 761262
Type BLA
Sponsor ABBVIE INC Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761262 Skyrizi risankizumab-rzaa 351(a) Rx 2026-06-01
Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 SKYRIZI RISANKIZUMAB-RZAA INJECTABLE;SUBCUTANEOUS 150MG No No
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 5 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0074-5015 Skyrizi risankizumab-rzaa AbbVie Inc. BLA Current 0074-5015 Skyrizi risankizumab-rzaa AbbVie Inc. BLA Current 0074-5015 Skyrizi risankizumab-rzaa AbbVie Inc. BLA Current 0074-5015 Skyrizi risankizumab-rzaa AbbVie Inc. BLA Current 0074-5015 Skyrizi risankizumab-rzaa AbbVie Inc. BLA Current